J7601 Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg
Billable / valid for submission HCPCS Release 2026Q3
Short description: Ensifentrine inh 3 mg
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| 2026Q3 | 2026-07-01 | current | Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg | yes |
Related codes in J76
- J7604 Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram
- J7605 Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms
- J7606 Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms
- J7607 Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg
- J7608 Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram
- J7609 Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg
- J7610 Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg
- J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg
- J7612 Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg
- J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg
- J7614 Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg
- J7615 Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg
- J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme
- J7622 Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7624 Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7626 Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg
- J7627 Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg
- J7628 Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7629 Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7631 Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams